Page last updated: 2024-10-19

niacinamide and Spinocerebellar Ataxias

niacinamide has been researched along with Spinocerebellar Ataxias in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research Excerpts

ExcerptRelevanceReference
"Spinocerebellar ataxia type 1 (SCA1) is a genetic disorder characterized by severe ataxia associated with progressive loss of cerebellar Purkinje cells."1.39Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1. ( Battaglia, G; Biagioni, F; Bucci, D; Cannella, M; Fazio, F; Gradini, R; Lionetto, L; Mascio, G; Nicoletti, F; Notartomaso, S; Puliti, A; Scarselli, P; Signore, M; Simmaco, M; Weisz, F; Zappulla, C, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Stoyas, CA1
Bushart, DD1
Switonski, PM1
Ward, JM1
Alaghatta, A1
Tang, MB1
Niu, C1
Wadhwa, M1
Huang, H1
Savchenko, A1
Gariani, K1
Xie, F1
Delaney, JR1
Gaasterland, T1
Auwerx, J1
Shakkottai, VG1
La Spada, AR1
Notartomaso, S1
Zappulla, C1
Biagioni, F1
Cannella, M1
Bucci, D1
Mascio, G1
Scarselli, P1
Fazio, F1
Weisz, F1
Lionetto, L1
Simmaco, M1
Gradini, R1
Battaglia, G1
Signore, M1
Puliti, A1
Nicoletti, F1

Other Studies

2 other studies available for niacinamide and Spinocerebellar Ataxias

ArticleYear
Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7.
    Neuron, 2020, 02-19, Volume: 105, Issue:4

    Topics: Animals; Calcium; Cell Line; Cerebellum; Female; Homeostasis; Humans; Male; Mice; Mice, Inbred C57BL

2020
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.
    Molecular brain, 2013, Nov-19, Volume: 6

    Topics: Amides; Animals; Cerebellum; Chromatography, High Pressure Liquid; Disease Models, Animal; Gene Expr

2013